Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 13 citing articles:

Nanomaterials in cancer immunotherapy: targeting cancer-associated fibroblasts
Zhongsong Zhang, Long Chen
Cancer Nanotechnology (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
A mitochondria-interfering nanocomplex cooperates with photodynamic therapy to boost antitumor immunity
Zhijie Zhang, Qingfu Zhao, Qingqing Xu, et al.
Biomaterials (2025) Vol. 317, pp. 123094-123094
Closed Access
A novel silkworm excrement-derived nanomedicine integrating ferroptosis and photodynamic therapy, well-suitable for PD-L1-mediated immune checkpoint blockade
Yujun Bao, Guanghao Li, Mingyang Liu, et al.
Chemical Engineering Journal (2025) Vol. 505, pp. 159676-159676
Closed Access
Computer‐Aided Design of Self‐Assembled Nanoparticles to Enhance Cancer Chemoimmunotherapy via Dual‐Modulation Strategy
Xiaoting Shan, Ying Cai, Binyu Zhu, et al.
Advanced Healthcare Materials (2025)
Closed Access
Enzymatically responsive nanocarriers targeting PD-1 and TGF-β pathways reverse immunotherapeutic resistance and elicit robust therapeutic efficacy
Ying‐Tzu Yen, Zhifan Zhang, Anni Chen, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Targeting TRAP1-Dependent Metabolic Reprogramming to Overcome Doxorubicin Resistance in Quiescent Breast Cancer
Muhammad Zubair Saleem, Ruyi Huang, Yingying Huang, et al.
Drug Resistance Updates (2025), pp. 101226-101226
Open Access
Multifunctional nanoparticle-mediated targeting of metabolic reprogramming and DNA damage response pathways to treat drug-resistant triple-negative breast cancer
Sifeng Zhu, Chao Sun, Zimin Cai, et al.
Journal of Controlled Release (2025) Vol. 381, pp. 113601-113601
Closed Access
The Important Role of Lactylation in Regulating DNA Damage Repair and Tumor Chemotherapy Resistance: Findings from Two Back-to-Back Studies
Jia Li, Zhe‐Sheng Chen, Yihang Pan, et al.
Drug Resistance Updates (2024), pp. 101148-101148
Closed Access | Times Cited: 2
Vanadium Single-Atoms Coordinated Artificial Peroxidases as Biocatalyst-Linked Immunosorbent Assay for Highly-Sensitive Carcinoembryonic Antigen Immunoassay
Minjia Yuan, Rui Yan, Zhenyang Zhao, et al.
Biomaterials (2024) Vol. 316, pp. 123008-123008
Closed Access
Mitochondrial transfer of drug-loaded artificial mitochondria for enhanced anti-Glioma therapy through synergistic apoptosis/ferroptosis/immunogenic cell death
Mingzhu Song, Jiayu Yuan, Ge Zhang, et al.
Acta Biomaterialia (2024)
Closed Access
Overcoming radiation-induced PD-L1 upregulation by novel gadolinium-palladium nanoplatforms for enhanced tumor radio-immunotherapy
Kai Guo, Hui Liu, Mengmeng Zhang, et al.
Chemical Engineering Journal (2024), pp. 158754-158754
Closed Access
Targeting Metabolic Adaptation of Colorectal Cancer with Vanadium‐Doped Nanosystem to Enhance Chemotherapy and Immunotherapy
Qian Cheng, Yu‐Zhe Chen, Danyi Zou, et al.
Advanced Science (2024)
Open Access
Page 1

Scroll to top